| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/14/1992 | US5130322 Chroman derivatives |
| 07/14/1992 | US5130319 Pharmacologically active 2,5-dioxo-octahydro-imidazo [1,2-a]pyridines |
| 07/14/1992 | US5130318 Hypotensive agents and for treatment of congestive heart failure |
| 07/14/1992 | US5130317 Immunosuppressants and fibrosuppressants for metabolism of collagen |
| 07/14/1992 | US5130315 Treatment of psychosis |
| 07/14/1992 | US5130313 Serotonin antagonists, their preparation and medications containing them |
| 07/14/1992 | US5130311 Analgesics or antiinflammatory agents |
| 07/14/1992 | US5130310 Substituted benzo[b]pyrans, processes for their preparation, their use and pharmaceutical preparations based on these compounds |
| 07/14/1992 | US5130309 Aryloxy and aryloxyalklazetidines as antiarrhythmic and anticonvulsant agents |
| 07/14/1992 | US5130308 Method of treating hormone dependent tumors with diamine-platinum (ii) complex compounds |
| 07/14/1992 | US5130305 Cyclophosphamide - sodium bicarbonate lyophilizates |
| 07/14/1992 | US5130304 N-heterocyclic propylidene-1,1-bisphosphonic acids, their production and a pharmaceutical composition |
| 07/14/1992 | US5130303 Drug effect-enhancing agent for antitumor drug |
| 07/14/1992 | US5130302 Boronated nucleoside, nucleotide and oligonucleotide compounds, compositions and methods for using same |
| 07/14/1992 | US5130301 Treatment of hypoxia, antiischemic disorders and metabolic disorders |
| 07/14/1992 | US5130300 Method for enhancing growth of mammary parenchyma |
| 07/14/1992 | US5130299 Method for enhancing growth of mammary parenchyma |
| 07/14/1992 | US5130242 Culture of fungi |
| 07/14/1992 | US5130241 Clavam derivatives and its enzymatic preparation |
| 07/14/1992 | US5130145 Pharmaceutical compositions with anit-cancer activity and method for the treatment of cancer |
| 07/14/1992 | US5130140 Dry compression to form tablets from free-flowing particles by dry mixing with high shear, drying and milling |
| 07/14/1992 | US5130139 Coadministering lysosomac uptake inhibiting agent |
| 07/14/1992 | US5130126 Polymer-drug conjugate and a method of producing it |
| 07/14/1992 | US5130061 Ester interchange and dilution with ethanol |
| 07/14/1992 | US5129950 Process of improving activity of herbicides and fertilizers using N-(2-hydroxyethyl)-acetamide or -propanamide |
| 07/14/1992 | CA1305286C 1,3,4,-thiadiazoles |
| 07/14/1992 | CA1305176C Tetrahydronaphthaline and indane derivatives |
| 07/14/1992 | CA1305166C 1-hydroxy-3-(n-methyl-n-proplylamino)propane-1,1- diphosphonic acid, pharmaceutical compositions and methods of use |
| 07/14/1992 | CA1305157C Pyrazol-3-amines |
| 07/14/1992 | CA1305152C Oxazolidin-2-one derivatives as hypoglycemic agents |
| 07/14/1992 | CA1305151C Antiallergy and antiinflammatory agents |
| 07/14/1992 | CA1305150C Derivatives of spiro (4,5) decane, process for their preparation and pharmaceutical compositions containing the same |
| 07/14/1992 | CA1305149C Dihydropyridine-5-phosphonic acid cyclic ester |
| 07/14/1992 | CA1305147C Benzo¬5,6|cycloheptapyridines, compositions and methods of use |
| 07/14/1992 | CA1305141C2 9-(1,3-dihydroxy-2-propoxymethyl)guanine as antiviral agent |
| 07/14/1992 | CA1305140C2 Protected n -9-(1,3-dihydroxy-2-propoxymethyl) guanine derivatives |
| 07/14/1992 | CA1305139C 9-(1,3-dihydroxy-2-propoxymethyl)guanine as antiviral agent |
| 07/14/1992 | CA1305138C Antiviral acyclic nucleoside derivatives and their preparation |
| 07/14/1992 | CA1305137C Ring open nucleoside analogues |
| 07/14/1992 | CA1305136C Derivatives of all-trans- and 13-cis retinoic acid and methods for preparing same |
| 07/14/1992 | CA1305135C2 N-6 substituted adenosine derivatives as cardiac vasodilators |
| 07/14/1992 | CA1305059C Stabilized menadione bisulfite formulations and their preparation |
| 07/14/1992 | CA1305058C Parenteral suspension containing diclofenac |
| 07/14/1992 | CA1305056C Method and compositions for reducing neurotoxic injury |
| 07/14/1992 | CA1305054C2 Encapsulation of antineoplastic agents in liposomes |
| 07/14/1992 | CA1305053C Synthetic polymeric drugs |
| 07/12/1992 | WO1992012132A1 Acridine derivatives |
| 07/12/1992 | WO1992011853A1 Amino-substituted pyrimidines, derivatives and methods of use therefor |
| 07/12/1992 | CA2100351A1 Amino-substituted pyrimidines, derivatives and methods of use therefor |
| 07/12/1992 | CA2059142A1 11-hydroxyaporphines and their biologically active salt forms as 5-ht1a inhibitors |
| 07/12/1992 | CA2058805A1 Indazole-substituted five- membered heteroaromatic compounds |
| 07/11/1992 | WO1992012151A1 N-alkyl quinuclidinium salts as substance p antagonists |
| 07/11/1992 | WO1992011862A1 Hyperglycemic compositions |
| 07/11/1992 | CA2100163A1 N-alkyl quinuclidinium salts |
| 07/11/1992 | CA2059110A1 1-piperazinyl-2-butenes and 2-butynes, intermediates thereof, a process for their preparation and their use as medicaments |
| 07/11/1992 | CA2058884A1 Substituted alkenoic acid and its derivatives |
| 07/11/1992 | CA2058793A1 Method for treatment for pulmonary disease |
| 07/11/1992 | CA2058699A1 Trifluoromethyl 1-carba(1-dethia)cephems |
| 07/10/1992 | WO1992012159A1 Bridged cyclic ketal derivatives |
| 07/10/1992 | WO1992012141A1 N-hydroxyurea derivatives as antiallergy and antiinflammatory agents |
| 07/10/1992 | WO1992012131A1 3-hydroxypyridin-4-one derivatives as pharmaceutical compositions |
| 07/10/1992 | CA2100257A1 Bridged cyclic ketal derivatives |
| 07/10/1992 | CA2100158A1 3-hydroxypyridin-4-one derivatives as pharmaceutical compositions |
| 07/09/1992 | WO1992011367A2 Lipid receptors for microorganisms and corresponding adhesins, dna sequences encoding adhesins, and use thereof |
| 07/09/1992 | WO1992011365A1 Liver enriched transcription factor |
| 07/09/1992 | WO1992011275A1 13-dimethyl fr-900506 derivative and the use as an immunosuppressive agent |
| 07/09/1992 | WO1992011269A1 Novel methylenebisphosphonic acid derivatives |
| 07/09/1992 | WO1992011267A1 Novel methylenebisphosphonic acid derivatives |
| 07/09/1992 | WO1992011265A1 OXO-TETRAHYDROPYRIDAZINYL-PYRAZOLO[4,3-b]-1,4-BENZOXAZINES |
| 07/09/1992 | WO1992011263A1 Method of making camptothecin and camptothecin analogs |
| 07/09/1992 | WO1992011261A1 4-azatricyclo[2.2.1.02,6]heptanes and pharmaceutical compositions |
| 07/09/1992 | WO1992011235A1 N-(mercaptoalkyl)amides |
| 07/09/1992 | WO1992011017A2 Use of sialyllactose for the treatment of arthritis |
| 07/09/1992 | WO1992011016A1 Pharmaceutical composition containing uridine 5'-triphosphate for the treatment of cystic fibrosis |
| 07/09/1992 | WO1992011015A1 Use of host cell phospholipids for inhibiting microbial colonization |
| 07/09/1992 | WO1992011010A1 New 3,4-dihydroisoquinoline derivates and new pharmaceutical use of carbocyclically and heterocyclically annulated dihydropyridines |
| 07/09/1992 | WO1992011009A1 Euthanasia compositions |
| 07/09/1992 | WO1992011008A1 Thiangazole as therapeutic agent for viral diseases |
| 07/09/1992 | WO1992011005A1 Use of thromboxane a2 receptor antagonists to prevent degenerative processes in the penile tissue |
| 07/09/1992 | WO1992011004A1 Fenalamides as therapeutic agents against viral diseases |
| 07/09/1992 | WO1992011003A1 Pharmaceutical compositions |
| 07/09/1992 | WO1992010996A1 Enhanced bioavailability pharmaceutical composition containing probucol |
| 07/09/1992 | WO1992010995A1 Novel compositions |
| 07/09/1992 | DE4041688A1 Therapeutisches mittel zur bekaempfung von viruserkrankungen Therapeutic agents for controlling virus diseases |
| 07/09/1992 | DE4039561A1 Verwendung von antigestagenen zur herstellung von arzneimitteln Use of antigestagens for the preparation of medicaments |
| 07/09/1992 | CA2098917A1 New 3,4-dihydroisoquinoline derivatives and new pharmaceutical use of carbocyclically and heterocyclically annulated dihydropyridines |
| 07/09/1992 | CA2098733A1 Lipid receptors for microorganisms and corresponding adhesins, dna sequences encoding adhesins, and use thereof |
| 07/09/1992 | CA2098730A1 Compositions |
| 07/09/1992 | CA2076005A1 Use of thromboxane-a2-receptor antagonists for the prevention of reduction of degenerative process in the penile tissue |
| 07/09/1992 | CA2058878A1 Benzisoxazole and benzisothiazole derivatives; process for preparing the same and pharmaceutical compositions containing them |
| 07/09/1992 | CA2058868A1 Method of inhibiting parasitic activity |
| 07/08/1992 | WO1992012161A1 Novel pyrimido-benzothiazines |
| 07/08/1992 | EP0494119A1 Use of 1,3-oxathiolane nucleoside analogues in the treatment of hepatitis B |
| 07/08/1992 | EP0494071A2 Trifluoromethylketone tripeptide derivatives |
| 07/08/1992 | EP0494063A2 Method for inhibiting IgE production |
| 07/08/1992 | EP0494057A1 Hydrolytic stabilizer for water soluble bis-quaternary pyridinium oximes |
| 07/08/1992 | EP0494047A1 Use of carbazones for the treatment of rheumatoid diseases |
| 07/08/1992 | EP0494010A1 1-Substituted 4-(4-imidazolyl) piperidines, process for their preparation and their therapeutic applications |
| 07/08/1992 | EP0494005A1 Multicomponent agent or kit for the preparation of the sulphoconjugated forms of pyridino-, pyrimidino- or triazino-N-oxyde compounds and method of application thereof |
| 07/08/1992 | EP0494002A2 Use of certain esters of hexahydro-8-hydroxy-2, 6-methano-2H-quinolizin-3(4H)-one and related compounds for the preparation of medicaments for treating cognitive disorders |